Skip to main content

Table 4 Factors associated with rtPA in the male dyslipidemic stroke population.

From: Gender and thrombolysis therapy in stroke patients with incidence of dyslipidemia

 

B Value

Wald

Odds Ratio

95% C.I.

Lower

For OR

Upper

P Value

Age

0.005

0.142

1.005

0.981

1.029

0.707

BMI

-0.010

0.175

0.991

0.947

1.036

0.676

NIH Stroke Scale

-0.130

8.409

0.879

0.805

0.959

0.004*

Risk of Mortality GWTG

0.062

1.228

1.064

0.954

1.186

0.268

Race

0.237

0.645

1.268

0.711

2.261

0.422

Atrial Fibrillation

0.719

4.537

2.053

1.059

3.978

0.033*

Coronary Artery Disease

0.015

0.003

1.015

0.613

1.682

0.953

Carotid Artery Stenosis

0.875

4.426

2.400

1.062

5.424

0.035*

Diabetes

-0.035

0.007

0.965

0.420

2.217

0.934

Congestive Heart Failure

0.431

1.297

1.539

0.733

3.230

0.255

Hypertension

-0.339

0.528

0.712

0.285

1.778

0.467

Previous Stroke

0.579

4.798

1.785

1.063

2.998

0.028*

Previous TIA

-0.256

0.576

0.774

0.400

1.500

0.448

Peripheral Vascular Disease

0.377

0.704

1.457

0.605

3.512

0.401

History of Smoking

-0.426

1.986

0.653

0.361

1.181

0.159

Antiplatelet medication

-0.628

4.589

0.534

0.301

0.948

0.032*

Antihypertensive medication

-0.321

0.679

0.725

0.338

1.557

0.410

Cholesterol Reducer

-0.226

0.562

0.798

0.442

1.441

0.454

Antidiabetic medication

0.235

0.265

1.265

0.517

3.092

0.607

  1. Positive B values (Adj, OR > 1) denote variables more associated with rtPA exclusion while negative B values (Adj. OR < 1) denote variables more associated with rtPA inclusion. Multicollinearity and interactions among independent variables were checked. Hosmer-Lemeshow test (P = 0.356), Classification table (overall correctly classified percentage = 66.7%), and area under the ROC curve (AUC = 0.726) were applied to check the model fitness